Verona Pharma ADR (VRNA) is near the top in its industry group according to InvestorsObserver. VRNA gets an overall rating of 75. That means it scores higher than 75 percent of stocks. Verona Pharma ADR gets a 88 rank in the Biotechnology industry. Biotechnology is number 27 out of 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 75 would rank higher than 75 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What’s Happening With Verona Pharma ADR Stock Today?
Verona Pharma ADR (VRNA) stock is trading at $23.06 as of 1:29 PM on Wednesday, Jan 18, a loss of -$0.63, or -2.66% from the previous closing price of $23.69. The stock has traded between $22.75 and $23.80 so far today. Volume today is light. So far 300,516 shares have traded compared to average volume of 1,589,337 shares. Click Here to get the full Stock Report for Verona Pharma ADR stock.